blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2201135

EP2201135 - INDIVIDUALIZED CANCER TREATMENTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.07.2011
Database last updated on 06.11.2024
Most recent event   Tooltip29.07.2011Application deemed to be withdrawnpublished on 31.08.2011  [2011/35]
Applicant(s)For all designated states
Duke University
2812 Erwin Road, Suite 306
Durham, NC 27705 / US
[2010/26]
Inventor(s)01 / POTTI, Anil
101 Lake Ridge Place
Chapel Hill NC 27516 / US
02 / DRESSMAN, Holly, K.
4606 Carlton Crossing Drive
Durham NC 27713 / US
03 / NEVINS, Joseph, R.
100 York Place
Chapel Hill NC 27517 / US
 [2010/26]
Representative(s)Kehoe, Laura Ellen, et al
Keltie LLP
No.1 London Bridge
London SE1 9BA / GB
[N/P]
Former [2010/26]Kehoe, Laura Ellen, et al
Keltie Fleet Place House 2 Fleet Place
London EC4M 7ET / GB
Application number, filing date08833249.929.09.2008
[2010/26]
WO2008US78150
Priority number, dateUS20070995910P28.09.2007         Original published format: US 995910 P
[2010/26]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009043022
Date:02.04.2009
Language:EN
[2009/14]
Type: A2 Application without search report 
No.:EP2201135
Date:30.06.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 02.04.2009 takes the place of the publication of the European patent application.
[2010/26]
Search report(s)International search report - published on:EP16.07.2009
ClassificationIPC:C12Q1/68
[2010/26]
CPC:
C12Q1/6886 (EP,US); A61P35/00 (EP); C12Q2600/106 (EP,US);
C12Q2600/158 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/26]
Extension statesALNot yet paid
BANot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:INDIVIDUALISIERTE KREBSBEHANDLUNGEN[2010/26]
English:INDIVIDUALIZED CANCER TREATMENTS[2010/26]
French:TRAITEMENTS DU CANCER INDIVIDUALISÉS[2010/26]
Entry into regional phase27.04.2010National basic fee paid 
27.04.2010Designation fee(s) paid 
27.04.2010Examination fee paid 
Examination procedure27.04.2010Examination requested  [2010/26]
30.06.2010Amendment by applicant (claims and/or description)
13.10.2010Despatch of a communication from the examining division (Time limit: M04)
24.02.2011Application deemed to be withdrawn, date of legal effect  [2011/35]
31.03.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/35]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.10.2010
Fees paidRenewal fee
24.08.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]  - "Affymetrix GeneChip Human Genome U133 Array Set HG-U133A", GEO,, (20020311), XP002254749 [X] 34 * the whole document *
 [X]  - "Single-sided, three-layer HD-DVD", III VS REVIEW, ELSEVIER SCIENCE PUBLISHERS, OXFORD, GB, vol. 19, no. 7, ISSN 0961-1290, (20060901), page 12, (20060901), XP025108945 [X] 36 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0961-1290(06)71795-1
 [YD]  - POTTI ANIL ET AL, "Genomic signatures to guide the use of chemotherapeutics", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 12, no. 11, ISSN 1078-8956, (20061101), pages 1294 - 130, (20061027), XP002494154 [YD] 1-12,24-28 * abstract * * page 1294 - page 1297 * * page 1299 - page 1300 * * figure 6 *

DOI:   http://dx.doi.org/10.1038/nm1491
    [ ] - POTTI ANIL ET AL, "Supplementary online material of Genomic signatures to guide the use of chemotherapeutics", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 12, no. 11, (20061101), URL: http://www.nature.com/nm/journal/v12/n11/suppinfo/nm1491_S1.html, (20090206), XP002513949 [ ] * figure s2 * * pages 3-4 * * pages 6-8 *
 [YD]  - GYORFFY BALAZS ET AL, "Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations", INTERNATIONAL JOURNAL OF CANCER, (200604), vol. 118, no. 7, ISSN 0020-7136, pages 1699 - 1712, XP002513950 [YD] 1-12,24-28 * page 1699 * * page 1701 - page 1706 * * figure 2 *

DOI:   http://dx.doi.org/10.1002/ijc.21570
 [PX]  - HSU DAVID S ET AL, "Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.", JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY 1 OCT 2007, (20071001), vol. 25, no. 28, ISSN 1527-7755, pages 4350 - 4357, XP002513951 [PX] 1-12,24-28,34 * the whole document *

DOI:   http://dx.doi.org/10.1200/JCO.2007.11.0593
 [A]  - GIOVANNETTI ELISA ET AL, "Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells", MOLECULAR PHARMACOLOGY, (200507), vol. 68, no. 1, ISSN 0026-895X, pages 110 - 118 URL, XP002513966 [A] 1-12,24-28 * abstract *

DOI:   http://dx.doi.org/10.1124//MOL.104.009373
Examination   - SANDERCOCK J ET AL, "First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence.", BRITISH JOURNAL OF CANCER 7 OCT 2002 LNKD- PUBMED:12373593, (20021007), vol. 87, no. 8, ISSN 0007-0920, pages 815 - 824, XP007914845
    - LEBWOHL D ET AL, "Clinical development of platinum complexes in cancer therapy: an historical perspective and an update", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB LNKD- DOI:10.1016/S0959-8049(98)00224-X, (19980901), vol. 34, no. 10, ISSN 0959-8049, pages 1522 - 1534, XP004285042

DOI:   http://dx.doi.org/10.1016/S0959-8049(98)00224-X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.